ScholarIQanswers from OpenAlex

New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation

PaperCitations, authors & open-access status

New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation have?

ScholarIQcitation count

New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation has 77 citations in the OpenAlex counts ScholarIQ stores.

When was New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation published?

ScholarIQyear

New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation has 2016 year in the ScholarIQ index.

What is the open-access status of New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation?

ScholarIQoa status

New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation has closed oa status in the ScholarIQ index.

What is the DOI of New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation?

ScholarIQdoi

The DOI for New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation is on the source record.

What is the PMID of New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation?

ScholarIQpmid

The PMID for New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation is on the source record.

What is the OpenAlex record for New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation?

ScholarIQopenalex

The OpenAlex for New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial